Role of Exercise and Metabolism in Heart Failure with Normal Ejection fraction

Progress in Cardiovascular Diseases

Volumn 49, Issue 4, 2007, Pages 263-274

  Marwick, Thomas H ^a   Wong, Chiew Y ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTATION; ARTICLE; DIABETES MELLITUS; DIASTOLIC HEART FAILURE; DYSPNEA; EXERCISE; HEART EJECTION FRACTION; HEART FAILURE; HEART FUNCTION; HEART MUSCLE; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART WORK; HEMODYNAMICS; HUMAN; METABOLIC DISORDER; METABOLISM; PATHOPHYSIOLOGY; STRESS; SYSTOLE; SYSTOLIC HEART FAILURE; VASCULAR DISEASE;

ANIMALS; CARDIAC OUTPUT, LOW; CHRONIC DISEASE; DIABETES COMPLICATIONS; DIASTOLE; EXERCISE TOLERANCE; HUMANS; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; OBESITY; RISK FACTORS; STROKE VOLUME; SYSTOLE; VENTRICULAR FUNCTION, LEFT;

EID: 33845541392     PISSN: 00330620     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcad.2006.08.006     Document Type: Article

References (107)

1. Fang Z.Y., Prins J.B., and Marwick T.H. Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. Endocr Rev 25 (2004) 543-567
2. Trost S.U., Belke D.D., Bluhm W.F., et al. Overexpression of the sarcoplasmic reticulum Ca(2+)-ATPase improves myocardial contractility in diabetic cardiomyopathy. Diabetes 51 (2002) 1166-1171
3. Abe T., Ohga Y., Tabayashi N., et al. Left ventricular diastolic dysfunction in type 2 diabetes mellitus model rats. Am J Physiol Heart Circ Physiol 282 (2002) H138-H148
4. Flarsheim C.E., Grupp I.L., and Matlib M.A. Mitochondrial dysfunction accompanies diastolic dysfunction in diabetic rat heart. Am J Physiol 271 (1996) H192-H202
5. Gotzsche O., Darwish A., Hansen L.P., et al. Abnormal left ventricular diastolic function during cold pressor test in uncomplicated insulin-dependent diabetes mellitus. Clin Sci (Lond) 89 (1995) 461-465
6. Regensteiner J.G., Sippel J., McFarling E.T., et al. Effects of non-insulin-dependent diabetes on oxygen consumption during treadmill exercise. Med Sci Sports Exerc 27 (1995) 875-881
7. Boyer J.K., Thanigaraj S., Schechtman K.B., et al. Prevalence of ventricular diastolic dysfunction in asymptomatic, normotensive patients with diabetes mellitus. Am J Cardiol 93 (2004) 870-875
8. Zabalgoitia M., Ismaeil M.F., Anderson L., et al. Prevalence of diastolic dysfunction in normotensive, asymptomatic patients with well-controlled type 2 diabetes mellitus. Am J Cardiol 87 (2001) 320-323
9. Poirier P., Bogaty P., Garneau C., et al. Diastolic dysfunction in normotensive men with well-controlled type 2 diabetes: importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy. Diabetes Care 24 (2001) 5-10
10. Raev D.C. Which left ventricular function is impaired earlier in the evolution of diabetic cardiomyopathy? An echocardiographic study of young type I diabetic patients. Diabetes Care 17 (1994) 633-639
11. Astorri E., Fiorina P., Contini G.A., et al. Isolated and preclinical impairment of left ventricular filling in insulin-dependent and non-insulin-dependent diabetic patients. Clin Cardiol 20 (1997) 536-540
12. Nicolino A., Longobardi G., Furgi G., et al. Left ventricular diastolic filling in diabetes mellitus with and without hypertension. Am J Hypertens 8 (1995) 382-389
13. Andersen N.H., Poulsen S.H., Helleberg K., et al. Impact of essential hypertension and diabetes mellitus on left ventricular systolic and diastolic performance. Eur J Echocardiogr 4 (2003) 306-312
14. Rubler S., Dlugash J., Yuceoglu Y.Z., et al. New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol 30 (1972) 595-602
15. Vered A., Battler A., Segal P., et al. Exercise-induced left ventricular dysfunction in young men with asymptomatic diabetes mellitus (diabetic cardiomyopathy). Am J Cardiol 54 (1984) 633-637
16. Yu C.M., Lin H., Yang H., et al. Progression of systolic abnormalities in patients with "isolated" diastolic heart failure and diastolic dysfunction. Circulation 105 (2002) 1195-1201
17. Hansen A., Johansson B.L., Wahren J., et al. C-peptide exerts beneficial effects on myocardial blood flow and function in patients with type 1 diabetes. Diabetes 51 (2002) 3077-3082
18. Fang Z.Y., Yuda S., Anderson V., et al. Echocardiographic detection of early diabetic myocardial disease. J Am Coll Cardiol 41 (2003) 611-617
19. Andersen N.H., Poulsen S.H., Eiskjaer H., et al. Decreased left ventricular longitudinal contraction in normotensive and normoalbuminuric patients with Type II diabetes mellitus: a Doppler tissue tracking and strain rate echocardiography study. Clin Sci (Lond) 105 (2003) 59-66
20. Vinereanu D., Nicolaides E., Tweddel A.C., et al. Subclinical left ventricular dysfunction in asymptomatic patients with Type II diabetes mellitus, related to serum lipids and glycated haemoglobin. Clin Sci (Lond) 105 (2003) 591-599
21. Saraiva R.M., Duarte D.M., Duarte M.P., et al. Tissue Doppler imaging identifies asymptomatic normotensive diabetics with diastolic dysfunction and reduced exercise tolerance. Echocardiography 22 (2005) 561-570
22. von Bibra H., Thrainsdottir I.S., Hansen A., et al. Tissue Doppler imaging for the detection and quantitation of myocardial dysfunction in patients with type 2 diabetes mellitus. Diab Vasc Dis Res 2 (2005) 24-30
23. Fang Z.Y., Schull-Meade R., Leano R., et al. Screening for heart disease in diabetic subjects. Am Heart J 149 (2005) 349-354
24. Fang Z.Y., Leano R., and Marwick T.H. Relationship between longitudinal and radial contractility in subclinical diabetic heart disease. Clin Sci (Lond) 106 (2004) 53-60
25. Fang Z.Y., Sharman J., Prins J.B., et al. Determinants of exercise capacity in patients with type 2 diabetes. Diabetes Care 28 (2005) 1643-1648
26. Andersen N.H., Poulsen S.H., Poulsen P.L., et al. Effects of blood pressure lowering and metabolic control on systolic left ventricular long axis function in type 2 diabetes mellitus. Eur J Echocardiogr 6 (2005) S47
27. von Bibra H., Hansen A., Dounis V., et al. Augmented metabolic control improves myocardial diastolic function and perfusion in patients with non-insulin dependent diabetes. Heart 90 (2004) 1483-1484
28. Rajagopalan R., Rosenson R.S., Fernandes A.W., et al. Association between congestive heart failure and hospitalization in patients with type 2 diabetes mellitus receiving treatment with insulin or pioglitazone: a retrospective data analysis. Clin Ther 26 (2004) 1400-1410
29. Fang Z.Y., Schull-Meade R., Downey M., et al. Determinants of subclinical diabetic heart disease. Diabetologia 48 (2005) 394-402
30. Mottram P.M., Haluska B., Leano R., et al. Effect of aldosterone antagonism on myocardial dysfunction in hypertensive patients with diastolic heart failure. Circulation 110 (2004) 558-565
31. Asif M., Egan J., Vasan S., et al. An advanced glycation endproduct cross-link breaker can reverse age-related increases in myocardial stiffness. Proc Natl Acad Sci USA 97 (2000) 2809-2813
32. Liu J., Masurekar M.R., Vatner D.E., et al. Glycation end-product cross-link breaker reduces collagen and improves cardiac function in aging diabetic heart. Am J Physiol Heart Circ Physiol 285 (2003) H2587-H2591
33. Ohno M., Cheng C.P., and Little W.C. Mechanism of altered patterns of left ventricular filling during the development of congestive heart failure. Circulation 89 (1994) 2241-2250
34. Carroll J.F., Summers R.L., Dzielak D.J., et al. Diastolic compliance is reduced in obese rabbits. Hypertension 33 (1999) 811-815
35. Backman L., Freyschuss U., Hallberg D., et al. Cardiovascular function in extreme obesity. Acta Med Scand 193 (1973) 437-446
36. de Divitiis O., Fazio S., Petitto M., et al. Obesity and cardiac function. Circulation 64 (1981) 477-482
37. Alaud-din A., Meterissian S., Lisbona R., et al. Assessment of cardiac function in patients who were morbidly obese. Surgery 108 (1990) 809-818
38. Crisostomo L.L., Araujo L.M., Camara E., et al. Comparison of left ventricular mass and function in obese versus nonobese women <40 years of age. Am J Cardiol 84 (1999) 1127-1129 [A11]
39. Zarich S.W., Kowalchuk G.J., McGuire M.P., et al. Left ventricular filling abnormalities in asymptomatic morbid obesity. Am J Cardiol 68 (1991) 377-381
40. Grossman E., Oren S., and Messerli F.H. Left ventricular filling in the systemic hypertension of obesity. Am J Cardiol 68 (1991) 57-60
41. Pascual M., Pascual D.A., Soria F., et al. Effects of isolated obesity on systolic and diastolic left ventricular function. Heart 89 (2003) 1152-1156
42. Wong C.Y., O'Moore-Sullivan T., Leano R., et al. Alterations of left ventricular myocardial characteristics associated with obesity. Circulation 110 (2004) 3081-3087
43. Chakko S., Mayor M., Allison M.D., et al. Abnormal left ventricular diastolic filling in eccentric left ventricular hypertrophy of obesity. Am J Cardiol 68 (1991) 95-98
44. Peterson L.R., Waggoner A.D., Schechtman K.B., et al. Alterations in left ventricular structure and function in young healthy obese women: assessment by echocardiography and tissue Doppler imaging. J Am Coll Cardiol 43 (2004) 1399-1404
45. 2). Am J Cardiol 94 (2004) 1087-1090
46. Scaglione R., Dichiara M.A., Indovina A., et al. Left ventricular diastolic and systolic function in normotensive obese subjects: influence of degree and duration of obesity. Eur Heart J 13 (1992) 738-742
47. Garavaglia G.E., Messerli F.H., Nunez B.D., et al. Myocardial contractility and left ventricular function in obese patients with essential hypertension. Am J Cardiol 62 (1988) 594-597
48. Karason K., Wallentin I., Larsson B., et al. Effects of obesity and weight loss on cardiac function and valvular performance. Obes Res 6 (1998) 422-429
49. Licata G., Scaglione R., Barbagallo M., et al. Effect of obesity on left ventricular function studied by radionuclide angiocardiography. Int J Obes 15 (1991) 295-302
50. Ferraro S., Perrone-Filardi P., Desiderio A., et al. Left ventricular systolic and diastolic function in severe obesity: a radionuclide study. Cardiology 87 (1996) 347-353
51. Iacobellis G., Corradi D., and Sharma A.M. Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart. Nat Clin Pract Cardiovasc Med 2 (2005) 536-543
52. Grandi A.M., Zanzi P., Piantanida E., et al. Obesity and left ventricular diastolic function: noninvasive study in normotensives and newly diagnosed never-treated hypertensives. Int J Obes Relat Metab Disord 24 (2000) 954-958
53. Wong C.Y., O'Moore-Sullivan T., Leano R., et al. Association of subclinical right ventricular dysfunction with obesity. J Am Coll Cardiol 47 (2006) 611-666
54. Wong C.Y., O'Moore-Sullivan T., Fang Z.Y., et al. Myocardial and vascular dysfunction and exercise capacity in the metabolic syndrome. Am J Cardiol 96 (2005) 1686-1691
55. Alexander J.K., and Peterson K.L. Cardiovascular effects of weight reduction. Circulation 45 (1972) 310-318
56. Alpert M.A., Terry B.E., and Kelly D.L. Effect of weight loss on cardiac chamber size, wall thickness and left ventricular function in morbid obesity. Am J Cardiol 55 (1985) 783-786
57. DasGupta P., Ramhanmdany E., Brigden G., et al. Improvement in left ventricular function after rapid weight loss in obesity. Eur Heart J 13 (1992) 1060-1066
58. Reid C.M., Dart A.M., Dewar E.M., et al. Interactions between the effects of exercise and weight loss on risk factors, cardiovascular haemodynamics and left ventricular structure in overweight subjects. J Hypertens 12 (1994) 291-301
59. Alpert M.A., Lambert C.R., Panayiotou H., et al. Relation of duration of morbid obesity to left ventricular mass, systolic function, and diastolic filling, and effect of weight loss. Am J Cardiol 76 (1995) 1194-1197
60. Karason K., Wallentin I., Larsson B., et al. Effects of obesity and weight loss on left ventricular mass and relative wall thickness: survey and intervention study. BMJ 315 (1997) 912-916
61. Wirth A., and Kroger H. Improvement of left ventricular morphology and function in obese subjects following a diet and exercise program. Int J Obes Relat Metab Disord 19 (1995) 61-66
62. Kanoupakis E., Michaloudis D., Fraidakis O., et al. Left ventricular function and cardiopulmonary performance following surgical treatment of morbid obesity. Obes Surg 11 (2001) 552-558
63. Marfella R., Esposito K., Siniscalchi M., et al. Effect of weight loss on cardiac synchronization and proinflammatory cytokines in premenopausal obese women. Diabetes Care 27 (2004) 47-52
64. Wong C.Y., Byrne N., O'Moore-Sullivan T., et al. Effect of weight loss from lifestyle intervention on subclinical cardiovascular dysfunction of obesity. Am J Cardiol (2006) [in press]
65. Miric G., Dallemagne C., Endre Z., et al. Reversal of cardiac and renal fibrosis by pirfenidone and spironolactone in streptozotocin-diabetic rats. Br J Pharmacol 133 (2001) 687-694
66. Coughlin S.S., Pearle D.L., Baughman K.L., et al. Diabetes mellitus and risk of idiopathic dilated cardiomyopathy. The Washington, DC Dilated Cardiomyopathy Study. Ann Epidemiol 4 (1994) 67-74
67. Gottdiener J.S., Arnold A.M., Aurigemma G.P., et al. Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study. J Am Coll Cardiol 35 (2000) 1628-1637
68. Yusuf S., Sleight P., Pogue J., et al. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 342 (2000) 145-153
69. Kannel W.B., Hjortland M., and Castelli W.P. Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol 34 (1974) 29-34
70. Hunt S.A., Baker D.W., Chin M.H., et al. ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure): Developed in Collaboration With the International Society for Heart and Lung Transplantation; Endorsed by the Heart Failure Society of America. Circulation 104 (2001) 2996-3007
71. Chen Y.T., Vaccarino V., Williams C.S., et al. Risk factors for heart failure in the elderly: a prospective community-based study. Am J Med 106 (1999) 605-612
72. He J., Ogden L.G., Bazzano L.A., et al. Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study. Arch Intern Med 161 (2001) 996-1002
73. Murphy N.F., Macintyre K., Stewart S., et al. Long-term cardiovascular consequences of obesity: 20-year follow-up of more than 15 000 middle-aged men and women (the Renfrew-Paisley study). Eur Heart J 27 (2006) 96-106
74. Kenchaiah S., Evans J.C., Levy D., et al. Obesity and the risk of heart failure. N Engl J Med 347 (2002) 305-313
75. Stone P.H., Muller J.E., Hartwell T., et al. The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis. The MILIS Study Group. J Am Coll Cardiol 14 (1989) 49-57
76. Bell D.S. Heart failure: the frequent, forgotten, and often fatal complication of diabetes. Diabetes Care 26 (2003) 2433-2441
77. Diamant M., Lamb H.J., Groeneveld Y., et al. Diastolic dysfunction is associated with altered myocardial metabolism in asymptomatic normotensive patients with well-controlled type 2 diabetes mellitus. J Am Coll Cardiol 42 (2003) 328-335
78. Garvey W.T., Hardin D., Juhaszova M., et al. Effects of diabetes on myocardial glucose transport system in rats: implications for diabetic cardiomyopathy. Am J Physiol 264 (1993) H837-H844
79. Rodrigues B., Cam M.C., Kong J., et al. Strain differences in susceptibility to streptozotocin-induced diabetes: effects on hypertriglyceridemia and cardiomyopathy. Cardiovasc Res 34 (1997) 199-205
80. Ingelsson E., Sundstrom J., Arnlov J., et al. Insulin resistance and risk of congestive heart failure. JAMA 294 (2005) 334-341
81. Galderisi M., Paolisso G., Tagliamonte M.R., et al. Is insulin action a determinant of left ventricular relaxation in uncomplicated essential hypertension?. J Hypertens 15 (1997) 745-750
82. Gough S.C., Smyllie J., Barker M., et al. Diastolic dysfunction is not related to changes in glycaemic control over 6 months in type 2 (non-insulin-dependent) diabetes mellitus. A cross-sectional study. Acta Diabetol 32 (1995) 110-115
83. Ruddy T.D., Shumak S.L., Liu P.P., et al. The relationship of cardiac diastolic dysfunction to concurrent hormonal and metabolic status in type I diabetes mellitus. J Clin Endocrinol Metab 66 (1988) 113-118
84. Beljic T., and Miric M. Improved metabolic control does not reverse left ventricular filling abnormalities in newly diagnosed non-insulin-dependent diabetes patients. Acta Diabetol 31 (1994) 147-150
85. Lo S.S., Leslie R.D., and Sutton M.S. Effects of type 1 diabetes mellitus on cardiac function: a study of monozygotic twins. Br Heart J 73 (1995) 450-455
86. Hirai J., Ueda K., Takegoshi T., et al. Effects of metabolic control on ventricular function in type 2 diabetic patients. Intern Med 31 (1992) 725-730
87. Uusitupa M., Siitonen O., Aro A., et al. Effect of correction of hyperglycemia on left ventricular function in non-insulin-dependent (type 2) diabetics. Acta Med Scand 213 (1983) 363-368
88. Shapiro L.M., Leatherdale B.A., Coyne M.E., et al. Prospective study of heart disease in untreated maturity onset diabetics. Br Heart J 44 (1980) 342-348
89. Hiramatsu K., Ohara N., Shigematsu S., et al. Left ventricular filling abnormalities in non-insulin-dependent diabetes mellitus and improvement by a short-term glycemic control. Am J Cardiol 70 (1992) 1185-1189
90. Sykes C.A., Wright A.D., Malins J.M., et al. Changes in systolic time intervals during treatment of diabetes mellitus. Br Heart J 39 (1977) 255-259
91. Mizushige K., Yao L., Noma T., et al. Alteration in left ventricular diastolic filling and accumulation of myocardial collagen at insulin-resistant prediabetic stage of a type II diabetic rat model. Circulation 101 (2000) 899-907
92. Strauer B.E., Motz W., and Vogt M. Impaired coronary flow reserve in NIDDM: a possible role for diabetic cardiopathy in humans. Diabetes 46 Suppl 2 (1997) S119-S124
93. Berg T.J., Snorgaard O., Faber J., et al. Serum levels of advanced glycation end products are associated with left ventricular diastolic function in patients with type 1 diabetes. Diabetes Care 22 (1999) 1186-1190
94. Alpert M.A. Obesity cardiomyopathy: pathophysiology and evolution of the clinical syndrome. Am J Med Sci 321 (2001) 225-236
95. Davis C.L., Kapuku G., Snieder H., et al. Insulin resistance syndrome and left ventricular mass in healthy young people. Am J Med Sci 324 (2002) 72-75
96. Smart N., and Marwick T.H. Exercise training for patients with heart failure: a systematic review of factors that improve mortality and morbidity. Am J Med 116 (2004) 693-706
97. Lloyd-Williams F., Mair F.S., and Leitner M. Exercise training and heart failure: a systematic review of current evidence. Br J Gen Pract 52 (2002) 47-55
98. Arena R., and Humphrey R. Relationship between ventilatory expired gas and cardiac parameters during symptom-limited exercise testing in patients with heart failure. J Cardiopulm Rehabil 21 (2001) 130-134
99. Myers J., Wagner D., Schertler T., et al. Effects of exercise training on left ventricular volumes and function in patients with nonischemic cardiomyopathy: application of magnetic resonance myocardial tagging. Am Heart J 144 (2002) 719-725
100. Belardinelli R., Georgiou D., Cianci G., et al. Exercise training improves left ventricular diastolic filling in patients with dilated cardiomyopathy. Clinical and prognostic implications. Circulation 91 (1995) 2775-2784
101. Gary R.A., Sueta C.A., Dougherty M., et al. Home-based exercise improves functional performance and quality of life in women with diastolic heart failure. Heart Lung 33 (2004) 210-218
102. Yu C.M., Li L.S., Lam M.F., et al. Effect of a cardiac rehabilitation program on left ventricular diastolic function and its relationship to exercise capacity in patients with coronary heart disease: experience from a randomized, controlled study. Am Heart J 147 (2004) e24
103. Tyni-Lenne R., Gordon A., Jansson E., et al. Skeletal muscle endurance training improves peripheral oxidative capacity, exercise tolerance, and health-related quality of life in women with chronic congestive heart failure secondary to either ischemic cardiomyopathy or idiopathic dilated cardiomyopathy. Am J Cardiol 80 (1997) 1025-1029
104. Kiilavuori K., Naveri H., Salmi T., et al. The effect of physical training on skeletal muscle in patients with chronic heart failure. Eur J Heart Fail 2 (2000) 53-63
105. Ades P.A., Waldmann M.L., Meyer W.L., et al. Skeletal muscle and cardiovascular adaptations to exercise conditioning in older coronary patients. Circulation 94 (1996) 323-330
106. Hambrecht R., Wolf A., Gielen S., et al. Effect of exercise on coronary endothelial function in patients with coronary artery disease. N Engl J Med 342 (2000) 454-460
107. Hambrecht R., Fiehn E., Weigl C., et al. Regular physical exercise corrects endothelial dysfunction and improves exercise capacity in patients with chronic heart failure. Circulation 98 (1998) 2709-2715